The study reported no difference in GWG, but improved lipid profile throughout pregnancy in the GLP1RA-pre-treated dams, a lasting reduction in circulating leptin and adiponectin levels and correction of fasting hyperinsulinemia (the latter in semaglutide-treated dams only). The gene discussed is ADIPOQ; the disease is hyperinsulinism.